COMPANY PROFILE

iZumi Bio

Explore full profile

Induced pluripotent stem cell (iPS) therapeutics developer

San Francisco, United StatesFounded 2007Marketing

Valuation $100–250M Last recorded · 2009

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About iZumi Bio

iZumi Bio, Inc. was a biotechnology firm specializing in induced pluripotent stem cell (iPS) technology to develop new therapeutics. Founded in 2007 and based in South San Francisco, California, the company focused on creating patient-specific cell lines for drug discovery and regenerative medicine. Its primary goal was to industrialize iPS technology for cellular reprogramming and directed differentiation of patient cells. The company had two main areas of focus: developing novel stem cell lines as alternatives to animal models in drug discovery and engineering these cells to treat neurodegenerative disorders.

The company's scientific team included notable researchers like John T. Dimos, Ph.D., whose work involved differentiating iPS cells from ALS patients into motor neurons. Thane Kreiner, Ph.D., served as the President and CEO, and John Walker later took on the CEO role. iZumi Bio secured $20 million in a Series A funding round in April 2009 from investors including Highland Capital Partners and Kleiner Perkins Caufield & Byers. In July 2009, iZumi Bio merged with Pierian to form iPierian, which was subsequently acquired by Bristol Myers Squibb in 2014.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2007
Headquarters: San Francisco, United States
Employees: 94
Open positions: None listed
Dealroom signal: 43.1/100
Industry: Media, Marketing
Sector: Marketing, Search Engine, Biotechnology, Video
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Jul 2009	$0	—	iPierian	—
SERIES A✓Equity / VC	Apr 2009	$20M	$80M	Kleiner Perkins · Highland Capital Partners	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

iZumi Bio website traffic

Latest recorded traffic for iZumi Bio is 150 monthly website visits. iZumi Bio's team grew 129.3% over the past year.

Latest monthly visits150 1-year team growth+129.3%

Monthly website visitsApr 2016–Mar 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
INInvisu.meA wizard that guides entrepreneurs to create their investor one pager/send-out deck in a clear, concise manner that gets them the meetings	Tel Aviv-Yafo, Israel	Operational	1	$100K	$400K
DSDSURGESMarketing	Narayanganj, Bangladesh	Operational
TRTriMobiTriMobi is one of the best Performance Marketing Network	Singapore, Singapore	Operational
LMLMNSOFTSOLUTIONSLMNSOFTSOLUTIONS is one of the fastest growing Website Designing Firm built in Hyderabad, Bangalore	Bengaluru, India	Operational
EXExlendureDigital marketing boutique which helps to optimize your business importance in the global market	Noida, India	Closed
PAPayOOMPayOOM is India's fastest growing and most loved affiliate network	Gurugram, India	Operational
LTLahari TechnologiesSearch marketing, domain registration, and many other solutions	Hyderabad, India	Operational
SMStudio III MarketingBest Marketing Company Los Angeles \| Online Marketing Agency	Glendale, United States	Operational